RMAM
ARNA

Raab & Moskowitz Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10
Closed – – 409
2014
Q4 		$0 Buy
+10
New +$406 ﹤0.01% 496

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Raab & Moskowitz Asset Management's ARNA Position: Q1 2015 in Review

Raab & Moskowitz Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2015, closing a stake of 10 shares.

Raab & Moskowitz Asset Management first reported a position in ARNA in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 122 funds tracked by Wall St. Rank hold ARNA as of Q1 2015.

  • Raab & Moskowitz Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 10 Arena Pharmaceuticals Inc shares in Q1 2015.
  • Raab & Moskowitz Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 1 quarter.
  • Raab & Moskowitz Asset Management's Arena Pharmaceuticals Inc position peaked at $0 in Q4 2014.
  • 122 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2015.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.